BCL2 and Miyoshi myopathy: Given that venetoclax is a well‐established Bcl‐2 inhibitor, we thereafter performed western blot analysis of Bcl‐2 protein levels in parental cells, venetoclax‐resistant cells and MM cells with LAPTM5 overexpression.